Logotype for Bayer AG

Bayer (BAYN) investor relations material

Bayer Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Bayer AG
Q3 2025 earnings summary12 Nov, 2025

Executive summary

  • Q3 2025 net sales reached €9.7 billion, up 1% currency and portfolio adjusted, but down 3% reported due to €450 million in FX headwinds.

  • Core EPS rose 137.5% year-over-year to €0.57, with 9M 2025 core EPS at €4.29, up 7%; free cash flow was €596 million, down 48% due to higher litigation payouts.

  • EBITDA before special items increased 21% to €1.5 billion, driven by Crop Science and cost reductions; EBITDA margin before special items improved to 15.6%.

  • Litigation provisions increased by €934 million in Q3, with net income at -€963 million due to €1.1 billion in special charges for litigations.

  • Net financial debt reduced by 7% year-over-year to €32.7 billion, reflecting focused capital allocation and FX effects.

Financial highlights

  • Q3 2025 EBITDA before special items was €1.5 billion, up 21% year-over-year, mainly from Crop Science and reconciliation gains.

  • Q3 2025 reported EBITDA was €0.5 billion, impacted by special items; Q3 core net income was €0.6 billion, with a core tax rate of 27.7%.

  • 9M 2025 EBITDA before special items was €7.7 billion, down 1% year-over-year.

  • Free cash flow for Q3 was €596 million, lower than prior year due to higher settlement payouts.

  • Special items for 2025 now expected at €3.5–4 billion, mainly litigation-related.

Outlook and guidance

  • Full-year 2025 group outlook confirmed at constant currencies; FX headwinds expected to persist into 2026.

  • FY 2025 group net sales expected at €46.0–48.0 billion (-1% to +3% cpa), with EBITDA before special items of €9.7–10.2 billion.

  • Core EPS forecasted at €4.80–5.30, free cash flow €1.5–2.5 billion, and net financial debt €31.0–32.0 billion.

  • Crop Science and Pharmaceuticals expected to meet full-year top and bottom line targets; Consumer Health sales growth guidance lowered to -1% to +1%.

  • More detailed 2026 guidance to be provided with FY 2025 results in February.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Bayer earnings date

Logotype for Bayer AG
Q4 202525 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Bayer earnings date

Logotype for Bayer AG
Q4 202525 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Bayer AG operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The company researches, develops, manufactures, and markets prescription products primarily for the areas of cardiology and women's healthcare; and specialty therapeutics in the areas of oncology, hematology, and ophthalmology. It is also involved in developing over-the-counter medications and dietary supplements.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage